Ahmed M. Rammah, Alaa Meshref, Ebram Soliman, Islam Nasser Abd Elaziz, Enmar Habib, Ahmed Yehia Abdelaziz, Ahmed H. Abozamel
{"title":"Does dutasteride reduce the bleeding in transurethral resection of the prostate in patients on antiplatelet drugs?","authors":"Ahmed M. Rammah, Alaa Meshref, Ebram Soliman, Islam Nasser Abd Elaziz, Enmar Habib, Ahmed Yehia Abdelaziz, Ahmed H. Abozamel","doi":"10.1097/cu9.0000000000000226","DOIUrl":null,"url":null,"abstract":"Abstract Purpose The aim of this study was to assess the effect of a 4-week dutasteride treatment on reducing the intraoperative and postoperative bleeding, as well as the amount and duration of irrigation required to clear the urine after transurethral resection of the prostate (TURP) ≥50 g in men receiving the antiplatelet drug (APD). Materials and methods This double-blind randomized clinical trial included patients with a prostate size ≥50 g who were indicated for TURP and were already receiving APD. The study was conducted in the Urology Department of Cairo University over a 12-month period. Routine preoperative laboratory investigations were performed in all patients. Moreover, baseline prostate size, serum prostate-specific antigen level, and International Prostate Symptom Score were estimated. The patients were randomly divided into 2 equal groups (groups A and B). Group A, the dutasteride group, received dutasteride (0.5 mg) once daily for 4 weeks. Group B, the placebo group, received a placebo capsule once daily for 4 weeks. Both groups underwent bipolar TURP. Fifteen patients were excluded from the study; 9 patients from group A and 6 patients from group B, either due to drug intolerability or loss follow-up. Results The mean blood loss was insignificant between the 2 groups immediately after and 24 hours after surgery (Δ hemoglobin: 1.41 ± 0.63 g/dL vs. 1.48 ± 0.54 g/dL, 2.12 ± 0.70 g/dL vs. 2.31 ± 0.78 g/dL, respectively, p = 0.631, p = 0.333; Δ hematocrit: 2.97% ± 1.51% vs. 3.16% ± 1.36%, 4.96% ± 1.87% vs. 5.73% ± 4.39%, respectively, p = 0.610, p = 0.380). However, there were significant differences in duration of indwelling urethral catheter (5.10 ± 0.55 days vs. 5.80 ± 1.79 days, p = 0.048), duration of bladder irrigation (13.60 ± 2.85 hours vs. 16.33 ± 6.62 hours, p = 0.044), and the amount of saline used for bladder irrigation (11.03 ± 2.30 L vs. 13.87 ± 6.13 L, p = 0.046) between group A and group B. respectively. Conclusions Treatment with dutasteride for 4 weeks before TURP in men receiving APD did not significantly reduce intraoperative or postoperative bleeding after TURP but could significantly reduce the duration of indwelling catheter placement, as well as the duration and amount of saline irrigation.","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"28 1","pages":"0"},"PeriodicalIF":0.9000,"publicationDate":"2023-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/cu9.0000000000000226","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract Purpose The aim of this study was to assess the effect of a 4-week dutasteride treatment on reducing the intraoperative and postoperative bleeding, as well as the amount and duration of irrigation required to clear the urine after transurethral resection of the prostate (TURP) ≥50 g in men receiving the antiplatelet drug (APD). Materials and methods This double-blind randomized clinical trial included patients with a prostate size ≥50 g who were indicated for TURP and were already receiving APD. The study was conducted in the Urology Department of Cairo University over a 12-month period. Routine preoperative laboratory investigations were performed in all patients. Moreover, baseline prostate size, serum prostate-specific antigen level, and International Prostate Symptom Score were estimated. The patients were randomly divided into 2 equal groups (groups A and B). Group A, the dutasteride group, received dutasteride (0.5 mg) once daily for 4 weeks. Group B, the placebo group, received a placebo capsule once daily for 4 weeks. Both groups underwent bipolar TURP. Fifteen patients were excluded from the study; 9 patients from group A and 6 patients from group B, either due to drug intolerability or loss follow-up. Results The mean blood loss was insignificant between the 2 groups immediately after and 24 hours after surgery (Δ hemoglobin: 1.41 ± 0.63 g/dL vs. 1.48 ± 0.54 g/dL, 2.12 ± 0.70 g/dL vs. 2.31 ± 0.78 g/dL, respectively, p = 0.631, p = 0.333; Δ hematocrit: 2.97% ± 1.51% vs. 3.16% ± 1.36%, 4.96% ± 1.87% vs. 5.73% ± 4.39%, respectively, p = 0.610, p = 0.380). However, there were significant differences in duration of indwelling urethral catheter (5.10 ± 0.55 days vs. 5.80 ± 1.79 days, p = 0.048), duration of bladder irrigation (13.60 ± 2.85 hours vs. 16.33 ± 6.62 hours, p = 0.044), and the amount of saline used for bladder irrigation (11.03 ± 2.30 L vs. 13.87 ± 6.13 L, p = 0.046) between group A and group B. respectively. Conclusions Treatment with dutasteride for 4 weeks before TURP in men receiving APD did not significantly reduce intraoperative or postoperative bleeding after TURP but could significantly reduce the duration of indwelling catheter placement, as well as the duration and amount of saline irrigation.
摘要:本研究的目的是评估接受抗血小板药物(APD)治疗的男性患者接受4周的度他雄胺治疗对减少术中和术后出血的影响,以及经尿道前列腺切除术(TURP)≥50 g后清尿所需的冲洗量和时间。材料和方法本双盲随机临床试验纳入了前列腺大小≥50 g且已接受APD的TURP患者。这项研究在开罗大学泌尿科进行了为期12个月的研究。所有患者术前均行常规实验室检查。此外,评估基线前列腺大小、血清前列腺特异性抗原水平和国际前列腺症状评分。随机分为A、B两组,A组为杜他雄胺组,给予杜他雄胺0.5 mg,每日1次,连用4周。B组,安慰剂组,每天服用一次安慰剂胶囊,持续4周。两组均行双相TURP。15名患者被排除在研究之外;A组9例,B组6例,因药物不耐受或失去随访。结果两组患者术后即刻及术后24 h平均失血量差异无统计学意义(Δ血红蛋白分别为1.41±0.63 g/dL vs. 1.48±0.54 g/dL, 2.12±0.70 g/dL vs. 2.31±0.78 g/dL, p = 0.631, p = 0.333;Δ红细胞比容:分别为2.97%±1.51% vs. 3.16%±1.36%,4.96%±1.87% vs. 5.73%±4.39%,p = 0.610, p = 0.380)。两组患者留置导尿管时间(5.10±0.55天)比(5.80±1.79天,p = 0.048)、膀胱冲洗时间(13.60±2.85小时比(16.33±6.62小时),p = 0.044)、膀胱冲洗生理盐水用量(11.03±2.30 L比(13.87±6.13 L), p = 0.046。结论APD患者行TURP术前4周给予度他雄胺治疗并不能显著减少TURP术中及术后出血,但可显著减少留置导管时间、盐水冲洗时间及量。